Regen BioPharma Raises $125,000 and Secures $10 Million Equity Line
Regen BioPharma entered into two financing agreements with Coventry Enterprises on October 27, 2026: an unsecured $125,000 promissory note and an equity line of up to $10 million. The note carries $12,500 in guaranteed interest over 18 months.
Regen BioPharma entered into two financing agreements with Coventry Enterprises on October 27, 2026: an unsecured $125,000 promissory note and an equity line of up to $10 million. The note carries $12,500 in guaranteed interest over 18 months, and $71,557 of its proceeds was used to satisfy existin…